As of 2025-07-01, the Relative Valuation of Innoviva Inc (INVA) is (0.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.09 USD, the upside of Innoviva Inc based on Relative Valuation is -103.6%.
The range of the Relative Valuation is (8.37) - 10.61 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 13.0x | 10.8x |
| Forward P/E multiples | 13.4x - 20.8x | 17.2x |
| Fair Price | (8.37) - 10.61 | (0.72) |
| Upside | -141.7% - -47.2% | -103.6% |
| Date | P/E |
| 2025-06-26 | -21.43 |
| 2025-06-25 | -21.53 |
| 2025-06-24 | -21.74 |
| 2025-06-23 | -21.89 |
| 2025-06-20 | -22.07 |
| 2025-06-18 | -22.56 |
| 2025-06-17 | -22.54 |
| 2025-06-16 | -22.92 |
| 2025-06-13 | -22.80 |
| 2025-06-12 | -22.50 |
| 2025-06-11 | -22.46 |
| 2025-06-10 | -22.63 |
| 2025-06-09 | -22.68 |
| 2025-06-06 | -22.68 |
| 2025-06-05 | -22.25 |
| 2025-06-04 | -21.95 |
| 2025-06-03 | -21.65 |
| 2025-06-02 | -21.17 |
| 2025-05-30 | -20.57 |
| 2025-05-29 | -20.49 |
| 2025-05-28 | -20.10 |
| 2025-05-27 | -20.13 |
| 2025-05-23 | -19.94 |
| 2025-05-22 | -19.78 |
| 2025-05-21 | -19.92 |
| 2025-05-20 | -19.74 |
| 2025-05-19 | -19.58 |
| 2025-05-16 | -19.53 |
| 2025-05-15 | -19.27 |
| 2025-05-14 | -18.93 |
| 2025-05-13 | -19.19 |
| 2025-05-12 | -19.56 |
| 2025-05-09 | -19.51 |
| 2025-05-08 | -19.53 |
| 2025-05-07 | -19.70 |
| 2025-05-06 | -19.67 |
| 2025-05-05 | -19.70 |
| 2025-05-02 | -19.68 |
| 2025-05-01 | -19.60 |
| 2025-04-30 | -19.65 |
| 2025-04-29 | -19.47 |
| 2025-04-28 | -19.32 |
| 2025-04-25 | -19.17 |
| 2025-04-24 | -19.32 |
| 2025-04-23 | -19.31 |
| 2025-04-22 | -19.45 |
| 2025-04-21 | -19.22 |
| 2025-04-17 | -19.20 |
| 2025-04-16 | -19.02 |
| 2025-04-15 | -19.04 |